HedgeChatter

  • Home /
  • Tag Archives

BTX

BioTime Announces Fourth Quarter and Fiscal Year End 2013 Financial Results and Recent Corporate Accomplishments

[Business Wire] – BioTime, Inc. , today reported financial results for the fourth quarter and year ended December 31, 2013 and highlighted its fourth quarter and recent corporate acco moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here to view […]

March 17, 2014 Bystocknews , Comments Off on BioTime Announces Fourth Quarter and Fiscal Year End 2013 Financial Results and Recent Corporate Accomplishments read more

9:03 am BioTime announced it has sold 70K shares of a newly authorized Series A Convertible Preferred Stock for $3.5 mln. The Series A Preferred Stock carries a cumulative annual 3% preferred dividend or $1.50/share, in preference to BTX sh

moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here to view […]

March 6, 2014 Bystocknews , Comments Off on 9:03 am BioTime announced it has sold 70K shares of a newly authorized Series A Convertible Preferred Stock for $3.5 mln. The Series A Preferred Stock carries a cumulative annual 3% preferred dividend or $1.50/share, in preference to BTX sh read more

9:05 am BioTime provides financing and product development update; $12.6 mln raised since Oct 1, 2013 in at-the-market stock sales; Premvia 510(k) premarket notification submitted to FDA for review

moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here to view […]

March 3, 2014 Bystocknews , Comments Off on 9:05 am BioTime provides financing and product development update; $12.6 mln raised since Oct 1, 2013 in at-the-market stock sales; Premvia 510(k) premarket notification submitted to FDA for review read more

9:05 am BioTime provides financing and product development update; $12.6 mln raised since Oct 1, 2013 in at-the-market stock sales; Premvia 510(k) premarket notification submitted to FDA for review

moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here to view […]

March 3, 2014 Bystocknews , Comments Off on 9:05 am BioTime provides financing and product development update; $12.6 mln raised since Oct 1, 2013 in at-the-market stock sales; Premvia 510(k) premarket notification submitted to FDA for review read more

BioTime Provides Financing and Product Development Update

[Business Wire] – ALAMEDA, Calif.–(BUSINESSWIRE)– BioTime, Inc. (NYSE MKT: BTX) today announced the results of its capital raising activities since October 1, 2013 through its $25 million Controlled Equity Offering facility, and through sales of BioTim moreView todays social media effects on BTXView the latest stocks trending across Twitter. Click to view dashboardSee who BioTime is hiring next, click here […]

March 3, 2014 Bystocknews , Comments Off on BioTime Provides Financing and Product Development Update read more